Table 2

 In-hospital management according to GRACE risk score for patients presenting with an acute coronary syndrome

Unstable angina/NSTEMISTEMI
Low riskMedium riskHigh riskp ValueLow riskMedium riskHigh riskp Value
ACE, angiotensin-converting enzyme; CABG, coronary artery bypass grafting; GP, glycoprotein; GRACE, Global Registry of Acute Coronary Events; LMWH, low molecular weight heparin; MI, myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST segment elevation myocardial infarction; UFH, unfractionated heparin.
Number394454405704411926232359
Cardiac catheterisation2836 (72%)3689 (68%)2894 (51%)<0.0013236 (79%)1937 (74%)1342 (57%)<0.001
PCI1554 (40%)1907 (35%)1426 (25%)<0.0012466 (60%)1421 (54%)959 (41%)0.98
CABG298 (7.6%)425 (7.9%)361 (6.4%)0.006162 (4.0%)108 (4.2%)86 (3.7%)0.67
Fibrinolytics113 (2.9%)103 (1.9%)108 (1.9%)0.0011538 (38%)828 (32%)445 (19%)<0.001
Exercise tolerance test977 (25%)1205 (23%)915 (16%)<0.001807 (20%)414 (16%)238 (10%)<0.001
Echocardiography2096 (54%)2784 (52%)3250 (58%)<0.0012985 (74%)1982 (76%)1815 (78%)0.002
In-hospital drugs
    Aspirin3705 (94%)5080 (93%)5136 (90%)<0.0013948 (96%)2490 (95%)2147 (91%)<0.001
    Thienopyridine2009 (52%)2627 (49%)2292 (41%)<0.0012543 (62%)1485 (57%)1013 (44%)<0.001
    UFH1956 (50%)2496 (47%)2627 (47%)0.0012552 (63%)1527 (59%)1280 (55%)<0.001
    LMWH2263 (58%)3145 (58%)3160 (56%)0.0162052 (50%)1447 (56%)1251 (54%)<0.001
    GP IIb/IIIa inhibitor1008 (26%)1197 (22%)1002 (18%)<0.0011669 (41%)914 (35%)659 (28%)0.099
    ACE inhibitor2157 (55%)2911 (54%)3234 (57%)0.0042796 (68%)1861 (71%)1589 (68%)0.01
    β blocker3352 (85%)4533 (84%)4251 (75%)<0.0013706 (90%)2217 (85%)1615 (69%)<0.001
    Calcium antagonist1120 (29%)1745 (32%)1936 (34%)<0.001578 (14%)490 (19%)425 (18%)<0.001